Hemophilia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA guidance · 2013-12-06
PRAC considers benefits of Kogenate Bayer/Helixate NexGen outweigh risks in previously untreated patients
PRAC concluded that the benefits of Kogenate Bayer/Helixate NexGen outweigh the risks in previously untreated patients, informing risk-benef…